Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / S&P PHARMAC
-
Total 13F shares
-
4,123,920
-
Share change
-
+325,668
-
Total reported value
-
$172,487,399
-
Put/Call ratio
-
0.82%
-
Price per share
-
$41.83
-
Number of holders
-
76
-
Value change
-
+$14,291,081
-
Number of buys
-
33
-
Number of sells
-
40
Institutional Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q1 2017
As of 31 Mar 2017,
SPDR SERIES TRUST - S&P PHARMAC (XPH) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,123,920 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, MORGAN STANLEY, UBS Group AG, BANK OF AMERICA CORP /DE/, Wharton Business Group, LLC, Psagot Investment House Ltd., Baird Financial Group, Inc., CITIGROUP INC, TWO SIGMA SECURITIES, LLC, and WELLS FARGO & COMPANY/MN.
This page lists
76
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.